Tempus AI Total Current Liabilities 2023-2025 | TEM

Tempus AI total current liabilities from 2023 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
  • Tempus AI total current liabilities for the quarter ending March 31, 2025 were $0.336B, a 60.59% increase year-over-year.
  • Tempus AI total current liabilities for 2024 were $0.291B, a 25.12% increase from 2023.
  • Tempus AI total current liabilities for 2023 were $0.233B, a 33.51% increase from 2022.
  • Tempus AI total current liabilities for 2022 were $0.174B, a 0% decline from .
Tempus AI Annual Total Current Liabilities
(Millions of US $)
2024 $291
2023 $233
2022 $174
Tempus AI Quarterly Total Current Liabilities
(Millions of US $)
2025-03-31 $336
2024-12-31 $291
2024-09-30 $253
2024-06-30 $182
2024-03-31 $210
2023-12-31 $233
2023-09-30
2023-06-30
2023-03-31
2022-12-31 $174
Sector Industry Market Cap Revenue
Medical Medical Information Systems $10.988B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.332B 57.93
Hims & Hers Health (HIMS) United States $12.707B 132.02
IRhythm Technologies (IRTC) United States $4.490B 0.00
Inspire Medical Systems (INSP) United States $3.944B 61.63
Hinge Health (HNGE) United States $3.156B 0.00
Privia Health (PRVA) United States $2.783B 190.25
Enovis (ENOV) United States $1.694B 9.44
Clover Health Investments (CLOV) United States $1.613B 0.00
Schrodinger (SDGR) United States $1.592B 0.00
Phreesia (PHR) United States $1.482B 0.00
Omnicell (OMCL) United States $1.415B 24.96
Azenta (AZTA) United States $1.219B 56.66
10x Genomics (TXG) United States $1.164B 0.00
Fulgent Genetics (FLGT) United States $0.629B 0.00
Claritev (CTEV) United States $0.629B 0.00
Butterfly Network (BFLY) United States $0.571B 0.00
Talkspace (TALK) United States $0.561B 167.50
Veradigm (MDRX) United States $0.466B 0.00
Standard BioTools (LAB) United States $0.399B 0.00
TruBridge (TBRG) United States $0.357B 791.67
Outset Medical (OM) United States $0.316B 0.00
Health Catalyst (HCAT) United States $0.264B 0.00
Nyxoah SA (NYXH) Belgium $0.260B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.194B 0.00
EUDA Health Holdings (EUDA) Singapore $0.136B 0.00
KORU Medical Systems (KRMD) United States $0.129B 0.00
Pulmonx (LUNG) United States $0.126B 0.00
MDxHealth SA (MDXH) Belgium $0.104B 0.00
American Well (AMWL) United States $0.103B 0.00
CareCloud (CCLD) United States $0.085B 3.26
111 (YI) China $0.070B 0.00
HeartBeam (BEAT) United States $0.061B 0.00
P3 Health Partners (PIII) United States $0.051B 0.00
Zepp Health (ZEPP) Netherlands $0.034B 0.00
Zhongchao (ZCMD) China $0.030B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
MSP Recovery (MSPR) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00